Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease

Journal of Neural Transmission

Volumn 105, Issue 4-5, 1998, Pages 479-488

  Molina, J A ^a,d   Jimenez Jimenez F J ^b   Aguilar, M V ^c   Meseguer, I ^c   Mateos Vega, C J ^c   Gonzalez Munoz M J ^c   De Bustos, F ^a   Porta, J ^a   Orti Pareja M ^b   Zurdo, M ^b   Barrios, E ^b   Martinez Para M C ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d NONE   (Spain)

Author keywords

Alzheimer's disease; Cerebrospinal fluid levels; Copper; Iron; Manganese; Serum levels; Transition metals; Zinc

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; COPPER; IRON; MANGANESE; METAL; ZINC;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BODY MASS; BODY WEIGHT; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIETARY INTAKE; DISEASE DURATION; FEMALE; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MENTAL HEALTH; ONSET AGE; PRIORITY JOURNAL; ZINC BLOOD LEVEL;

AGED; ALZHEIMER DISEASE; BLOOD PROTEINS; COPPER; FEMALE; HUMANS; IRON; MALE; MANGANESE; METALS, HEAVY; NUTRITIONAL STATUS; REFERENCE VALUES; SPECTROPHOTOMETRY, ATOMIC; TRACE ELEMENTS; VITAMIN A; ZINC;

EID: 14444268040     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050071     Document Type: Article

References (57)

1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV). American Psychiatric Press, Washington DC
2. Basun H, Forssell LG, Wetterberg L, Winblad B (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm [Park Dis Dement Sect] 3: 231-258
3. Benzi G, Moretti A (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol Aging 16: 661-674
4. Burnet FM (1981) A possible role of zinc in the pathology of dementia. Lancet i: 186-188
5. Chvapil M (1976) Effect of zinc on cells and biomembranes. Med Clin North Am 60: 799-812
6. Connor JR, Tucker P, Johnson M, Snyder B (1993) Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease. Neurosci Lett 159: 88-90
7. Constantinidis J (1990) Maladie d'Alzheimer et la theorie du zinc. Encephale 16: 231-239
8. Constantinidis J (1991) Hypothesis regarding amyloid and zinc in the pathogenesis of Alzheimer disease: potential for preventive intervention. Alzheimer Dis Assoc Disord 5: 31-35
9. Corrigan FM, Reynolds GP, Ward NI (1993) Hippocampal tin, aluminum and zinc in Alzheimer's disease. Biometals 6: 149-154
10. Cuajungco MP, Lees GJ (1997) Zinc and Alzheimer's disease: is there a direct link? Brain Res Rev 23: 219-236
11. Deibel MA, Ehmann WD, Markesbery WR (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 143: 137-142
12. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin, and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114: 1953-1975
13. Donaldson J, McGregor D, LaBella F (1982) Manganese neurotoxicity: a model for free radical mediated neurodegeneration? Can J Physiol Pharmacol 60: 1398-1405
14. Dormandy TL (1978) Free-radical oxidation and antioxidants. Lancet i: 647-650
15. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12: 189-198
16. Goate AM (1997) Molecular genetics of Alzheimer's disease. Geriatrics 52 [Suppl 2]: S9-12
17. Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 31: 286-292
18. Griffiths PD, Crossman AR (1993) Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 4: 61-65
19. Gronek I, Kolomaznik M (1989) Serum zinc levels in various mental disorders. Zh Nevropatol Psikhiatr 89: 126-127
20. Hachinski VC, Ihift LD, Zilhka E, du Boulay GG, McAllister VL, Marshall J, Russell RW, Symov L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632-637
21. Halliwell B, Gutteridge JMC (1985) Oxigen-radicals and the nervous system. Trends Neurosci 8: 22-26
22. Halliwell B, Gutteridge JMC (1988) Iron as a biological prooxidant. ISI Atlas Sci Biochem 1: 48-52
23. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
24. Hershey CO, Hershey LA, Varnes A, Vibhakar SD, Lavin P, Strain WH (1983) Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations. Neurology 33: 1350-1353
25. Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F, Cuny G (1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35: 275-282
26. Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB (1990) Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm [Park Dis Dement Sect] 2: 327-340
27. Jiménez-Jiménez FJ, de Bustos F, Gasalla T, Ortí-Pareja M (1996) Estrés oxidativo y sistema nervioso central. In: Luquin MR, Jiménez-Jiménez FJ, Martínez-Vila E, Molina-Arjona JA, Bermejo-Pareja F, Coria-Balanzat F (eds) Mecanismos de muerte neuronal y neuroprotección en enfermedades neurológicas. Neurología 11 [Suppl 3]: 13-22
28. Kala SV, Hasinoff BB, Richardson JS (1996) Brain samples from Alzheimer's patients have elevated levels of loosely bound iron. Int J Neurosci 86: 263-269
29. Kapaki E, Segditsa J, Papageorgiou C (1989) Zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders. Acta Neurol Scand 79: 373-378
30. Katzman R, Kawas C (1994) The epidemiology of dementia and Alzheimer's disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 105-122
31. Kennard ML, Feldman H, Yamada T, Jefferies WA (1996) Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat Med 2: 1230-1235
32. Kuiper MA, Mulder C, van Kamp GJ, Scheltens P, Wolters EC (1994) Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy. J Neural Transm [Park Dis Dement Sect] 7: 109-114
33. Licastro F, Davis LJ, Mocchegiani E, Fabris N (1996) Impaired peripheral zinc metabolism in patients with senile dementia of probable Alzheimer's type as shown by low plasma concentrations of thymulin. Biol Trace Elem Res 51: 55-62
34. Loeffler DA, DeMaggio AJ, Juneau PL, Brickman CM, Mashour GA, Finkelman JH, Pomara N, LeWitt PA (1994) Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. Alzheimer Dis Assoc Disord 8: 190-197
35. Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA (1995) Transferrin and iron in normal. Alzheimer's disease, and Parkinson's disease brain regions. J Neurochem 65: 710-724
36. Loeffler DA, LeWitt PA, Juneau PL, Sima AA, Nguyen HU, DeMaggio AJ, Brickman CM, Brewer GJ, Dick RD, Troyer MD, Kanaley L (1996) Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res 738: 265-274
37. Markesbery WR, Ehmann WD, Hossain TIM, Alauddin M (1984) Brain manganese concentrations in aging and Alzheimer's disease. Neurotoxicology 5: 49-57
38. Marttila RJ, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in Parkinson's disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci 86: 321-331
39. McKahnn G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944
40. Meret S, Henkin RI (1971) Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin Chem 17: 369-373
41. Moreu E, Molinero LM, Fernández E (1990) R-Sigma: Base de datos bioestadística para un ordenador personal. Horus Hardware, Madrid
42. Morris CM, Kerwin JM, Edwardson JA (1994) Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus. Neurodegeneration 3: 267-275
43. Multhaup G, Schlicksupp A, Hesse L, Beher L, Ruppert T, Masters CL, Beyreuther K (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 271: 1406-1409
44. Olson AD, Hamlin WB (1969) A new method for serum iron and total iron-binding capacity by atomic absorption spectrophotometry. Clin Chem 15: 438-444
45. Plantin LO, Lying-Tunell U, Kristensson K (1987) Trace elements in the human central nervous system studied with neutron activation analysis. Biol Trace Element Res 13: 69-75
46. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 692-697
47. Sahu RN, Pandey RS, Subhash MN, Arya BY, Padmashree TS, Srinivas KN (1988) CSF zinc in Alzheimer's type dementia. Biol Psychiatry 9: 1-7
48. Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Loffler J, Richards JG (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62: 15-30
49. Schubert D, Chevion M (1995) The role of iron in beta amyloid toxicity. Biochem Biophys Res Commun 216: 702-707
50. Sulkava R, Haltia M, Paetau A, Wikstrom J, Palo J (1983) Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 46: 9-13
51. Tully CL, Snowdon DA, Markesbery WR (1995) Serum zinc, senile plaques, and neurofibrillary tangles: findings from the Nun Study. NeuroReport 6: 2105-2108
52. van Renshurg SJ, Carstens ME, Potocnik FC, Aucamp AK, Taljaard JJ (1993) Increased frequency of the transferrin C2 subtype in Alzheimer's disease. Neuroreport 4: 1269-1271
53. van Rensburg SJ, Carstens ME, Potocnik FC, van der Spuy G, van der Walt BJ, Taljaard JJ (1995) Transferrin C2 and Alzheimer's disease: another piece of the puzzle found? Med Hypotheses 44: 268-272
54. Ward NI, Mason JA (1987) Neutron activation analysis for identifying elemental status in Alzheimer's disease. J Radioanal Nucl Chem 113: 293-298
55. Wenstrup D, Ehmann WD, Markesbery WR (1990) Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res 533: 125-131
56. Youdim MBH (1988) Iron in the brain: implications for Parkinson's and Alzheimer's disease. Mt Sinai J Med 55: 97-101
57. Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC (1992) Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 21: 91-94